European Heart Journal

Article	Citations
Development and uptake of the National Heart Foundation of Australia Smart Heart Guideline App	8053
ESC 2021 named lectures: science, research, and innovation	3797
Single- vs dual-chamber ICDs to prevent from inappropriate shocks: the debate is still alive	3294
Association between family history and severity of coronary artery disease in a nationwide sample of patients with a first time myocardial infarction	1981
Fibroblast growth factor 21 and adipose tissue distribution in young adult with abdominal obesity	1730
Efficacy and safety of direct oral anticoagulants with diabetes and nonvalvular atrial fibrillation: a systematic review and meta-analysis	1488
Ticagrelor monotherapy versus dual anti-platelet therapy in patients undergoing percutaneous coronary intervention: a subgroup analysis of safety in multiple comorbidities	1402
The impact of diabetes mellitus on carotid atherosclerosis and arterial stiffness; results from the Corinthia study	1227
Evaluation of different late left ventricular remodeling definitions for predicting long-term outcomes in acute myocardial infarction patients undergoing percutaneous coronary intervention	961
Local areas of earlier repolarization cause epicardial repolarization heterogeneity in patients with apparently idiopathic ventricular fibrillation	884
His bundle pacing: safety, performance, and clinical outcomes in a single centre experience	818
Outcome and clinical profile of patients with newly detected atrial fibrillation and cardioembolic stroke	729
Abnormal left-sided blood volume, wall shear stress & energy loss in patients with repaired Tetralogy of Fallot identified by 4D flow MRI	663
Functional capacity and gender-related differences in Fabry disease	649
Trimetazidine as adjunctive therapy for decreasing major adverse cardiac events in coronary artery disease patients undergoing reperfusion strategy: a meta-analysis of randomized controlled trials	614
Injection drug use infective endocarditis: clinical features and therapeutic challanges	614
Aortic Z-scores in paediatric patients with marfan syndrome and other hereditary thoracic aortic diseases	604
Evolving trends in infective endocarditis over three decades in a developing country	582
Sex differences on new-onset heart failure in patients with known or suspected chronic coronary syndrome	514
The value of microRNA-122 in the diagnosis of coronary heart disease	507
Atrial fibrillation screening on holter monitoring after percutaneous patent foramen ovale closure: a prospective study	447
A blueprint for the continuation of comprehensive cardiac rehabilitation during the COVID-19 pandemic. An Australian single hospital experience	439
Correction to: The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies	413
Involvement of FAK in aortic dissection: potential role in aortic interstitial cells	365
First-degree relatives of type-2 diabetic patients and dysglycaemic patients have impaired endothelial function due to decreased bioavailability of nitric oxide	343

Risk of dementia according to smoking cessation after newly diagnosed atrial fibrillation: a nationwide cohort study	341
Trial leadership by women is associated with racial diversity among heart failure clinical trial participants: a systematic bibliometric review 2000–2020	291
Emotional and cardiovascular health: the impact of depression on cardiac autonomic activity	288
Accuracy and acute efficacy of a novel occlusion tool to guide cryoballoon-based pulmonary vein isolation	283
Contrast-induced nephropathy after staged balloon pulmonary angioplasty: lower risk compared with left-sided cardiac procedures	267
Prevalence of target organ damage in subjects with high-normal blood pressure without known cardiovascular and kidney disease	265
Role of telemedicine network provided by pharmacies to detect acute myocardial infarction in patients with chest pain during coronavirus pandemia	263
Association of Body mass index and clinical outcomes in patient with coronary artery disease undergoing percutaneous coronary intervention	255
Corrigendum to: The World Stroke Organization Brain & Heart Task Force: collaborations between stroke physicians and cardiologists	211
Effect of the number of parity on right heart chamber quantification	209
Hospital readmissions and economic burden associated with multivessel disease in the early period following acute myocardial infarction	197
Beta-blocker could show the prognostic impact in heart failure patients even on the regular hemodialysis	195
New Quality Standards Editor appointed for European Heart Journal	194
Sex-related differences in mortality following an admission for acute heart failure across left ventricular ejection fraction spectrum	191
Investigating the endothelin receptor antagonist aprocitentan in resistant hypertension: design and baseline characteristics of the PRECISION study	191
Prognostic value of heart rate reserve during dipyridamole stress echocardiography in patients with abnormal chronotropic response to exercise	190
Preponderance of right ventricular dysfunction in COVID-19 patients with inflammatory heart disease	186
Left atrial strain evaluation and prognostic value in constrictive pericarditis patients undergoing pericardiectomy	179
Speckle tracking during stress echocardiography using high frame rate imaging	179
The m6A methyltransferase METTL3 promotes hypoxic pulmonary arterial hypertension via targeting PTEN	171
Cryoablation versus anti-arrhythmic therapy for initial treatment of atrial fibrillation: a systematic review and meta-analysis	169
Exploring the cross-talk between liver and vessels through increased morning blood pressure in hypertension	168
Mechanoenergetic coupling in heart failure with preserved, mid-range and reduced left ventricular ejection fraction	167
‘Our real work’: medicine and poetry with Dr Adam Possner	165
Non-invasive diagnosis, antithrombotic treatment, and invasive management of ischaemic heart disease	165
Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled	158
Single-cell RNA sequencing of human fetal epicardium reveals novel markers and regulators of EMT	150
Anticoagulant profile of supplementary-dose enoxaparin in patients undergoing prolonged percutaneous coronary intervention	146
Influence of diabetes, heart failure, and NT-proBNP on cardiovascular outcomes in patients with atrial fibrillation – insights from a cohort study of 7,412 patients with extended follow-up	142
Additive prognostic value of exercise echocardiography in symptomatic patients with normal or abnormal left ventricular diastolic function	141
Comparison of coronary flow reserve feasibility and values in different stress echocardiography protocols: dobutamine, dipyridamole, exercise and rapid pacing	138
Prevalence and impact of frailty in patients with atrial fibrillation: a systematic review and meta-analysis	138
Long-term cardiopulmonary effects after Covid-19 infection	137
Association between lowering heart rate during IMPELLA support and favorable short-term outcome in patients with cardiogenic shock	137
First results of a regenerative transcatheter heart valve implant from autologous tissue in a long-term animal model	136
Leuko-platelet index as an independent predictor of in-hospital events in patients with non-ST elevation acute coronary syndrome	136
Sex differences in cardio-oncology: utilizing a genetic variant as a therapeutic target doxorubicin-induced cardiomyopathy	133
Indications for prescription and deprescription in multimorbid independently living elderly outpatients	132
Short- and intermediate-term mortality in women and men after surgical versus interventional revascularization and aortic valve replacement	128
Concomitant real-time measurement and correlation of contact force to baseline local impedance and local impedance drops in RF ablation of left and right atrial procedures	126
Incomplete functional reverse remodelling of the left ventricle one year after bariatric surgery. Insights from the prospective FatWest study	126
The bimodal rise and fall acute coronary syndromes curves paralleling COVID-19 outbreaks	125
Cardiac MRI risk factors predict atrial arrhythmia development in repaired tetralogy of Fallot patients	124
Effect of prophylactic and therapeutic low molecular weight heparins on mortality in 15,704 COVID-19 patients. A systematic review and a meta-analysis	124
Gene and protein expression profiles of selected molecular targets mediating electrophysiological function in pgc-1-alpha deficient murine ventricles	124
Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation has no impact on recurrences, cardiovascular events and mortality – insights from the German Ablation Registry	122
Usefulness of CHA2DS2-VASc scoring system for predicting risk of embolism in patients with cardiac tumours: a single-centre study	122
The efficiency of dapagliflozin as add-on therapy in obese patients with resistant hypertension and chronic kidney disease	121
Hemodynamic effects of balloon pulmonary angioplasty for the treatment of total and subtotal pulmonary artery occlusions in inoperable chronic thromboembolic pulmonary hypertension	118
The effectiveness of strict low-density lipoprotein cholesterol management in secondary prevention of Japanese patients	117

Percutaneous bioprosthetic aortic valve durability: results a single center after ten years of follow-up ago	113
Resveratrol regulates cytokine secretion by cardiac microvascular endothelium under hypoxia/reoxygenation condition	113
Mechanistic modelling of Virchows triad to assess thrombogenicity and stroke risk in atrial fibrillation patients	111
Timing of cardiovascular magnetic resonance imaging and diagnostic yield in patients with acute myocardial infarction with nonobstructive coronary arteries	111
Socioeconomic status and trends in utilization of catheter ablation in patients hospitalized with atrial fibrillation in united states	110
Impact of pacing-related differences on clinical and echocardiographic outcomes after TAVR with SAPIEN-3 valve	109
Predictors of survival in patients submitted to typical atrial flutter ablation	108
Endocardial pacing compared to epicardial left ventricle pacing and right ventricle pacing: a single center long term experience in a pediatric population	107
Utilising clinical data to personlaise boundary conditions significantly improves the accuracy of angiography based virtual FFR	107
New York Heart Association class change on heart failure patients with implantable devices: does it matters?	106
Routine versus clinically indicated use of chest X-rays in patients presenting with ST-elevation myocardial infarction	106
Traditional risk factor control in the Russian cohort of the hospital arm of EUROASPIRE V survey as compared to the whole study population	106
Frequency and prognostic impact of periprocedural myocardial infarction determined by various MI definitions in patients with chronic coronary syndromes undergoing percutaneous coronary intervention	106
European Heart Journal Team Heart Failure	105
Backup natural pacemaker found in the heart	104
Cumulative prognostic effect of diabetes and myocardial injury in patients attended in the emergency room	104
Influence of the speed of deflation of the stent delivery system in the myocardial blush and ST-segment resolution in primary angioplasty: a randomized study	103
Pharmacological blockade of histone methyltransferase SETD7 restores angiogenic response in experimental diabetes	102
Myocardial performance is impaired in cardiac amyloidosis: role of myocardial work-derived parameter in differential diagnosis with phenocopies and prognostic implications	101
Leadless pacemaker implant in the elderly: a safe and feasible solution	101
Severe tricuspid regurgitation worsens prognosis outcome after edge-to-edge mitral valve repair	100
Effect of interventional edge-to-edge repair in tricuspid regurgitation on ring dimensions	100
Role of prenatal cardiovascular magnetic resonance imaging in determining pregnancy risk in repaired Tetralogy of Fallot patients	99
A short and long-term outcomes of heart failure with midrange and preserved ejection fraction; developing countries perspective	99
Sex differences in the effect of family stress on risk of myocardial infarction and stroke in population 25–64 years: WHO program MONICA-psychosocial	99
Adherence to guidelines of diagnostic and therapeutic practices for suspected infections of cardiac implantable electronic devices	98
Use of sirolimus-coated balloon in de novo small vessel coronary lesions; Long-term follow-up from a single centre registry	98
Validity and utility of the questionnaire-based FRAIL scale in elderly patients with heart failure: findings from the FRAGILE-HF	98
Impact of diabetes mellitus on long-term survival after transcatheter mitral valve edge-to-edge repair	97
Prognostic significance of percutaneous coronary intervention associated blood loss in acute coronary syndrome	96
Obesity and decreased vibration perception associated with premature cardiovascular mortality in a single center prospective study of people with diabetes	96
The influence of metabolic activity of platelets on sensitivity to Acetylsalicylic acid in patients with coronary heart disease	96
Mitral and tricuspid annular abnormalities in hypereosinophilic syndrome – a three-dimensional speckle-tracking echocardiographic study	95
QRS narrowing predicts left ventricular reverse remodelling after resynchronization therapy in patients with end-stage heart failure	94
Different myocardial microRNA expression patterns are observed in pressure overload- and volume overload-induced chronic heart failure	93
Dyssynchronous cardiomyopathy in patients with WPW syndrome and its reversibility after RFA of accessory pathway	93
Gender bias in ACS management	93
Human hyperpolarized [1-13C] pyruvate CMR and adenosine stress test	93
Features of disorders of uric acid metabolism in male patients with hypertension and atrial fibrillation	93
Cognitive dysfunction and adverse events during oral anticoagulant: a prospective cohort study	92
Follow-up on new marker confirming the optimal status in the treatment of heart failure with reduced ejection fraction	92
Validation of HAS-BELD scoring system and risk factors of bleeding with warfarin among non-valvular atrial fibrillation patients	92
Reasons for antihypertensive medication nonadherence influence physician preferences for hypertension management	91
Impact of transcatheter aortic valve implantation on coronary flow reserve by transthoracic Doppler echocardiography 1-year after the intervention in severe aortic stenosis patients	91
Predictors of patient and system delay for primary percutaneous coronary intervention	91
Metabolic flexibility and reverse remodelling of the failing human heart	89
Can machine learning augment clinician adjudication of events in cardiovascular trials? A case study of major adverse cardiovascular events (MACE) across CVRM trials	89
Suspected heart failure: a clinical pattern that calls for action	89
Twenty-year experience and outcomes in a national paediatric pulmonary hypertension service	89
Whether women undergoing assisted reproductive technologies have an increased risk of cardiovascular disease remains an unanswered question	88
From cardiorenal to cardiovascular–kidney–metabolic syndromes	88
Identification of potential therapeutic targets for coronary artery disease based on protein array and Mendelian Randomization analysis	87
Role of myocardial performance index as predictor of in-hospital cardiac events in patients with acute myocardial infarction	87
Detecting cardiomyopathies in pregnancy and the postpartum period using ECG	86
Cardiovascular risk profile in Portugal: evidence from a large population-based cohort	85
An heart team stroke prevention decision-making process comparing percutaneous endocardial and thoracoscopic epicardial left atrial appendage occlusion	83
Protective effects of dapagliflozin on vascular remodeling in the carotid artery following balloon injury – potential role of angiotensin and purinergic signaling	83
Long-term mortality after myocardial infarction and stroke in a simple congenital heart disease population	82
Progression of liver fibrosis in pulmonary arterial hypertension	79
Predictors of clinical decompensation in patients presenting with COVID-19 in an urban hospital health system	79
Effectiveness and prognostic value of intravscular imaging in patients with left main coronary artery stenosis and heart failure	78
Induction of RAGE-NFkB signalling axis enhances SHP-2 tyrosine phosphatase expression resulting in deviant activation of diabetic monocytes	78
Impact of left atrial strain assessed with feature-tracking computed tomography on long-term mortality after transcatheter aortic valve implantation	78
Post-angioplasty myocardial blush grade for long term prognostication in acute coronary syndrome: a systematic review and meta-analysis	78
Morphological features of mitral annular calcification leading to systolic anterior motion of the mitral valve	76
The prognostic value of monocyte/ high-density lipoprotein ratio in chronic heart failure	76
Subdepression effect on the therapeutic and prophylactic activity of patients with existing coronary artery disease	75
Dynamic optimization of CRT pacing using a novel algorithm improves survival in a real-world cohort of patients	75
The efficacy of vericiguat on improving quality of life among patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis	75
Incidence and predictors of left atrial appendage thrombus on transoesophageal echocardiography before elective cardioversion	75
Circulating transforming growth factor-beta1 and progression of the mitral valve prolapse: fifteen-year follow-up	75
Automated non-invasive pressure-volume loop analysis of cardiac aging in a large cohort of healthy community dwellers	74
Comparison of mortality prediction scores in elderly patients with ICD for heart failure with reduced ejection fraction	74
Characteristics of warfarin underprescription in older adults with atrial fibrillation	74
Heartfelt welcome to ESC 2021	73
The effect of prolonged Intraaortic ballon pump (IABP) support on right ventricular function in end-stage heart failure	73
Myocardial Work and long-term prognosis in patients after ST-segment elevation acute myocardial infarction	73
Lifelong dietary omega-3 fatty acid reverses cardiac and vascular dysfunction via MMP-2 modulation in aged mice	72
Prognostic significance of non-sustained ventricular tachycardia on stored electrograms of heart failure patients with cardiovascular implantable electronic devices	71
Correlation of Seattle Angina Questionnaire score and post-procedural outcomes in patients undergoing multi-vessel coronary intervention	71

The combination of dulaglutide and dapagliflozin improves arterial stiffness, endothelial glycocalyx and albuminuria vs DPP-4 inhibitors independently of glycemic control	70
Direct comparison of adenosine- versus exercise echo-derived distal left anterior descending artery velocity reserve	70
Fluid responsiveness in patients under mechanical ventilation and low tidal volume ventilation through the pulse pressure variation after tidal volume challenge in the post-operative cardiac surgery	70
A fourteen-year experience on treatment of atrial fibrillation with radiofrequency ablation in Thailand: a real-world report from South East Asia	70
Comparison of peripheral artery plaque characteristics between ACS patients with plaque rupture and plaque erosion in culprit coronary artery: an OCT and ultrasound study	70
Fetal and maternal outcomes in patients with tetralogy of Fallot	70
Serial assessment of right ventricular function and deformation in patients with hypoplastic left heart syndrome: a cardiovascular magnetic resonance study	69
Cost and prescription trends of P2Y12 inhibitors in Australia over the last decade	69
Clinical outcomes in COVID-19 patients with in-hospital cardiac arrest – an insight from multi-centre data	69
A machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis	69
Predictability of cardiotoxicity at a Belgian cardio-oncology clinic without mandatory physician referral	68
Impact of induction therapy on outcomes after heart transplantation	68
Early screening for metabolic syndrome opens a window of opportunity - learnings from a long-term, population-based study	68
Colchicine and quality of life in patients with acute coronary syndromes: results from the COPS randomized trial	68
Kidney subclinical lesions in hypertension phenotypes defined by Home Blood Pressure Monitoring among young adults enrolled in a Family Health Strategy unit	67
Pulmonary arterial hypertension associated with congenital heart disease in children and adults: knowing the present to imagine the future	67
Impact of COVID-19 pandemics upon pulmonary hypertension patients: insights from BNP-PL national database	67
Clinical characteristics and natural history of pre-adolescent non-syndromic hypertrophic cardiomyopathy	66
Long-term durability of transcatheter aortic valve replacement: outcomes from a contemporary cohort from a tertiary reference center at 5-years and beyond	66
Antithrombotic strategy in patients with atrial fibrillation and acute coronary syndrome	66
Hypertension as a prognostic factor in the prediction of mortality in patients with COVID-19: a systematic review and meta-analysis	66
Predictors of mortality in patients with right-side and cardiac device-related infective endocarditis, the esc-eorp euro-endo registry	66
Dispatch of lay-responders is associated with bystander cardiopulmonary resuscitation, bystander defibrillation and 30-day survival following an out-of-hospital cardiac arrest	65
Association of neighbourhood-level poverty with outcomes and clinical care following atrial fibrillation diagnosis in a universal healthcare system	65
Fragmented qrs as a predictor of cardiac events in patients with cardiac sarcoidosis	65
Clinical characteristics and outcomes of myocardial infarction with nonobstructive coronary arteries	65
Echocardiogram in critically ill patients with COVID-19	65
The gender differences in the implementation and maintenance of a structured-enhanced education and follow-up program in primary prevention for coronary artery disease	65
Social-occupational impact and level of satisfaction in patients included in a remote monitoring pacemaker programme	65
Impact of parity on cardiac structure and function in apparently healthy pregnant women in Nigeria	64
A novel research platform for sudden cardiac death based on continuous, real-life, unlimited follow-up of a cohort of high-risk patients	64
Effects of cardiac rehabilitation on the two-year prognosis of patients with heart failure: a multicentre prospective cohort study	64
Clinical characteristics and in-hospital outcomes of patients coinfected with Chagas disease and SARS-CoV-2	64
Increased VO2 peak after a structured exercise-training program is associated with reduced levels of cardiac myosin binding protein C in patients with symptomatic chronic heart failure	64
Management and clinical outcome of patients with atrial fibrillation stratified by the 4S-AF scheme for structured characterization of atrial fibrillation: data from CODE-AF registry	63
Clinical factors predicting asymptomatic atrial fibrillation in Middle Eastern patients	63
Machine-learning fusion approach for the prediction of atrial fibrillation onset using photoplethysmographic-based smart device	62
The experience of cardiovascular professional training across europe: preliminary results from the ESC young cardiovascular professionals survey	62
The relationship between epigenetic age and myocardial infarction/acute coronary syndrome and in a population based nested case-control study	62
Incidence of cardiovascular events in patients with atrial fibrillation anticoagulated with rivaroxaban after 2.5 years of follow-up: not all is stroke or bleeding	62
Relationship between endothelium-dependent vasodilation, carotid intima-media thickness and atherosclerotic plaques: is it preserved in the elderly?	62
Comparison between a novel sirolimus-eluting bioresorbable scaffold with everolimus-eluting metallic stent in patients with coronary artery disease: three-year follow-up from the neovas rct study	61
Characteristics and prognosis of patients with elevated triglycerides in acute myocardial infarction: observational data from a large database over a 17 years period	61
Gender differences in health-related quality of life among coronary patients and the relation with comorbidity burden. Results from the ESC EORP EUROASPIRE V survey	60
The role of process mining tools in STEMI networks: where should we build a new primary PCI centre?	60
Low rate of worsening renal function after 2 years of treatment with edoxaban in patients from the ETNA-AF-Europe study	60
Novel insights into the management of German patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: baseline characteristics from the PERI-DYS study	60
Resistant hypertension improved after 3 months by measuring drug levels to identify non-adherence	60
A genetic risk score predicts recurrent events after myocardial infarction in young patients with a low level of traditional risk factors	59
Prognostic value of self-reported subjective exercise capacity in patients with acute dyspnea	59
The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure	59
Therapeutic components of an automated digital counselling intervention for chronic heart failure	59
12-month post-trial follow-up of participants in the Australian arm of the second low-dose colchicine trial	59
Prevalence and diagnostic yield of investigating t wave inversion in a large unselected pre-participation cohort of young Asian males	59
A machine-learning-based bio-psycho-social model for the prediction of non-obstructive and obstructive coronary artery disease	59
Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General Long-Term Registry	59
Weekly Journal Scan: The jury is still out on beta-blockers following acute myocardial infarction with preserved ejection fraction after the ABYSS trial	58
Gender disparities in ventricular tachycardia: evaluating clinical outcomes and interventions	58
European Research Council-funded grant: programming the epicardium to cure broken hearts	58
Prognostic impact of the serial change of a systemic inflammation-nutrition index in patients with heart failure with preserved ejection fraction: insights from pursuit-hfpef registry	58
Rate dependent complete right bundle block: a challenging diagnosis in Brugada syndrome	57
Circulating proteins and incident myocardial infarction: appraising sex-specific differences and causality	57
A rare splice-site variant in TNNT2: the need for ancestral diversity in genomic reference data sets	57
Common and divergent cellular aetiologies underlying hypoplastic left heart syndrome and hypoplastic right heart syndrome	57
Mixed valvular heart disease: diagnosis and management	57
Artificial intelligence and digital tools for design and execution of cardiovascular clinical trials	57
An update on the European Society of Cardiology Council of Cardio-Oncology	56
Arterial conduits for coronary bypass grafting: the set-point concept	56
Frankfurt scientists lead the way with funding for three visionary research projects	55
Double counting in meta-analyses: a statistical complication in cardiovascular medicine trials	55
Dilemmas on diagnosis and treatment of iron deficiency in patients after an episode of acute heart failure	55
Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site–derived extracellular vesicles from myocardial infarction patients	55
Predictive value of the left ventricular function in coronary artery disease: should we tailor risk-stratification for men and women?	54
Secondary prevention of cerebrovascular events in patients with “asymptomatic” atherosclerotic stenosis of the vertebral arteries	54
Protective effects of renal denervation based on MRI assessment of the brain in patients with resistant hypertension	54
Routine snuffbox approach do not reduce radial artery occlusion in comparison with conventional transradial access	54
Effect of concomitant atrioventricular valve regurgitation on the outcome after transcatheter aortic-valve implantation	54
The atherosclerosis profile by coronary CTA compared to the coronary artery calcium score (CACS) in a young symptomatic high-risk population between 19 and 49 years	54
Implications of ESC-high tthrombotic risk features and ARC-high bleeding risk criteria on clinical outcomes in all-comer patients undergoing PCI	54
Impact of chronic mitral regurgitation on 3D atrial size and mechanics. Insights from the prospective 3D-PRIME study	54
One-year follow-up of continuous aspiration mechanical thrombectomy for the management of intermediate-high and high-risk pulmonary embolism: what is the line between utility and futility?	53
Mediation analyses of the effect of ertugliflozin on hospitalisation for heart failure in patients with type 2 diabetes and atherosclerotic cardiovascular disease from the VERTIS CV trial	53
A comparison of long-term clinical outcomes between PCI and medical therapy in patients with chronic total occlusion in non-Infarct-related arteries after AMI PCI	53
Impact of frailty status on medium-term follow up in patients undergoing percutaneous transcatheter aortic valve implantation in a high-flow referral center with high procedural volumes	53
Achilles tendon thickness assessed by X-ray predicting a pathogenic mutation in familial hypercholesterolemia gene	53
Genesis of epicardial adipocytes and its association with progenitor markers, muscarinic receptor type 3 and b-blockers intake in patients with cardiovascular disease	53
Exploring phenotypes in hypertrophic cardiomyopathy with machine learning data integration. A multicentric, multimodality pilot study	53
Culprit-plaque morphology and residual SYNTAX score for predicting cardiovascular events in acute myocardial infarction: an optical coherence tomography study	53
Assessment of sexual and physical activity of patients after implantation of left ventricular assist device (LVAD)	53
Expression of Concern: Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk	52
Ventricular fibrillation amplitude spectral area as a guide to deliver the optimal energy level for defibrillation	52
Relationship between morphometric parameters of epicardial adipose tissue and adipocytokine profile in patients with myocardial infarction	52
Role of inflammation and comorbidities in the association of heart failure with incident cancer in the HUNT3 cohort	52
New insights into optimal duration of DAPT for high-risk “TWILIGHT-like” patients with diabetes mellitus undergoing PCI: a focus on diabetes mellitus as a high-risk patient group	52
The European Heart Journal’s top contributing institutions: the Royal Brompton and Harefield hospitals, UK	52